2813 SET7/SET9 Antibody #2813

"上海博耀生物销售SET7/SET9 Antibody #2813，CST原装品质，价格优惠，订购SET7/SET9 Antibody #2813，详情请咨询销售人员！产品

"上海博耀生物销售SET7/SET9 Antibody #2813，CST原装品质，价格优惠，订购SET7/SET9 Antibody #2813，详情请咨询销售人员！
产品详细参数如下>>>>

产品名称：SET7/SET9 Antibody #2813
货号：2813
品牌：CST(cell signaling)
抗体来源：Rabbit
克隆类型： Polyclonal
规格：

No.	Size	Price
2813S	100 ul (10 western blots)	询价

抗体应用：

Applications	Reactivity	Sensitivity	MW (kDa)	Source
W IF-IC	H M R Mk	Endogenous	48	Rabbit

Applications Key:  W=Western Blotting  IF-IC=Immunofluorescence (Immunocytochemistry)
Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Mon key
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on sequence homology.
特异性/敏感度： SET7/SET9 Antibody detects endogenous levels of total SET7/SET9 protein. This antibody does not cross-react with other SET domain-containing proteins.
来源及纯化方法： Polyclonal antibodies are produced by immunizing animals with a synthetic peptide corresponding to the human SET7/SET9 protein. Antibodies are purified by protein A and peptide affinity chromatography.
抗体背景：

SET7/SET9 is a member of the SET domain-containing family, and can specifically methylate Lys4 on histone H3 (1). Like most other lysine-directed histone methyltransferases, it contains a conserved catalytic SET domain originally identified in the Drosophila Su(var)3-9, Enhancer of zeste and Trithorax proteins. Histone methylation is a major determinant for the formation of active and inactive regions of the genome and is crucial for the proper programming of the genome during development (2,3). Methylation of histone H3 Lys4 enhances transcriptional activation by coordinating the recruitment of BPTF, a component of the NURF chromatin remodeling complex, and WDR5, a component of multiple histone methyltransferase complexes (4,5). In addition, methylation of lysine 4 blocks transcriptional repression by inhibiting the binding of the NURD histone deacetylation complex to the amino-terminal tail of histone H3 and interfering with SUV39H1-mediated methylation of histone H3 Lys9 (1). SET7/SET9 is highly active on free histone H3, but only very weakly methylates H3 within nucleosomes (1). Besides histones, SET7/SET9 also methylates Lys189 of the TAF10, a member of the TFIID transcription factor complex, and Lys372 of the p53 tumor suppressor protein (6,7). Methylation of TAF10 stimulates transcription in a promoter-specific manner by increasing the affinity of TAF10 for RNA polymerase II, which may potentiate pre-initiation complex formation (6). Methylation of p53 at Lys372 increases protein stability and leads to upregulation of target genes such as p21. Thus the loss of SET7/SET9 may represent another mechanism for the inactivation of p53 in human cancers (7).

关键词：CST，抗体，一抗{byao_back}{byao_back2}

相关产品：
Anti-Inhibin Alpha抑制素α抗体 Inhibin α
Anti-GLP-1 (7-36)胰高血糖素样肽-1抗体
ab103195/Anti-EFHC2 antibody
ab103708/Anti-AXUD1 antibody
Anti-PCDHGA10原钙粘蛋白γ10抗体
Anti-SP-A肺表面活性蛋白A抗体
ab103986/Anti-ANKMY2 antibody
ab10398/Anti-CCR6 antibody
Anti-NKA/Neurokinin A神经激肽A抗体
Anti-p38MAPK/MAPK14/p38Alpha丝裂原活化蛋白激酶p38α抗体
Anti-HHV8/ORF50人类疱疹病毒8抗体
ab100878/Anti-Factor XIa antibody
ab10365/Anti-CINC1 antibody
Anti-PCDHGA10原钙粘蛋白γ10抗体
Anti-Glucocorticoid receptor(GR)糖皮质激素受体抗体
Anti-CDKN1C/p57 Kip2周期蛋白依赖激酶抑制因子1C抗体"
本页产品地址：http://www.geilan.com/sell/show-3244606.html